Studies show blood test has potential to detect CTE in the living

09 September 2026, Saxony, Chemnitz: In the cleanroom of the Center for Micro- and Nanotechnologies (ZfM) in Chemnitz, Sascha Hermann, a research associate, examines a wafer under a microscope. Among other things, researchers at the ZfM are working on a new semiconductor platform that uses carbon nanotubes to analyze exhaled breath as a source of health indicators. The goal is to detect diseases and inflammation in the breath without drawing blood. Research is also being conducted on "neuromorphic computing." In this work, scientists are replicating the human brain on a chip. The goal is to process data millions of times over in parallel and in an energy-efficient manner. Potential applications include autonomous driving and industrial robotics. The center, based at Chemnitz University of Technology, has just celebrated its 35th anniversary. Plans for the future include a new cleanroom. According to current plans, the buildingwhich will cost approximately 68 million eurosis scheduled to be ready for occupancy in the mid-2030s. Photo: Hendrik Schmidt/dpa
picture alliance / Getty

WASHINGTON (AP) — Scientists stumbled onto a hint that measuring a toxic protein tied to Alzheimer's disease just might one day be useful in diagnosing a different brain disease in football players and others who have suffered repeated blows to the head.

Doctors evaluate symptoms such as mood swings and memory loss to try to tell if patients may have CTE, or chronic traumatic encephalopathy, a disease linked to concussions and other brain trauma. But other diseases cause similar symptoms, and a CTE diagnosis can only be confirmed by examining the brain after death.

Now two small studies are highlighting a new clue — that a blood test being developed to spot abnormal tau in the brains of Alzheimer's patients seems to also detect buildup of that protein in people with advanced CTE.

Tau normally supports neurons but in Alzheimer's, it tangles inside those nerve cells. Scientists are developing a blood test to track those tangles by detecting a particular tau fragment called eMTBR-tau243. But researchers at Washington University in St. Louis got a surprise when using autopsy records to study the new test – finding someone with high levels of that biomarker who didn't have Alzheimer's but CTE instead.

The researchers turned to a larger collection of autopsied brain and blood samples, eventually testing blood stored from 11 people classified as having CTE.

Compared to samples stored from healthy people, levels of eMTBR-tau243 were higher in those with advanced CTE, said study co-author Chihiro Sato, a WashU assistant neurology professor. That biomarker couldn't reliably identify early-stage CTE, the research team reported at a dementia meeting in Japan last week.

Separately, researchers at Boston University and Arizona's Banner Health were studying the same question using blood stored from 21 former professional or school football players who also donated their brain for research after death. Autopsies found 16 died with advanced CTE, two with earlier-stage CTE and three didn't have the disease.

Blood levels of that tau biomarker were significantly higher in the athletes with advanced CTE, the researchers reported Thursday at a scientific meeting in Boston. Adding to the complexity, five of those with CTE also had Alzheimer’s disease, resulting in the highest levels of that tau biomarker.

Both studies were published in the medical journal JAMA.

The possible CTE link is interesting but very preliminary, requiring much larger studies to see if there's a real connection, cautioned Northwestern University neuropathologist Dr. Rudolph Castellani, who wasn't involved with the research.

Abnormal tau is found in several additional brain diseases, which can overlap in older adults. Moreover, tau buildup in CTE is different from the type that occurs in Alzheimer's, Drs. Günter Höglinger and Carla Palleis of Germany's Ludwig Maximilian University of Munich wrote in an accompanying editorial in the journal.

They also stressed the need for far more research, while saying the two studies together "represent an important step" in the quest to one day detect CTE in living patients.

XRedditFacebookWhatsAppEmailSMS

More Stories